An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins

Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2014.0362
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

The Future of Biosimilar Insulins

Diabetes Spectrum
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Trastuzumab Biosimilar on Track for Approval

Cancer Discovery
Oncology
2017English

Pcp67 - Regulatory Requirements and Scientific Rationale for Biosimilar: Us vs. European Union.

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Requirements for US Regulatory Approval of the International Thermonuclear Experimental Reactor (ITER)

1993English

An Overview of the Biosimilar Market in the Us

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives

Frontiers in Immunology
AllergyImmunology
2016English

Plasma Measurements: An Overview of Requirements and Status

2008English

An Overview of NCA-Based Algorithms for Transcriptional Regulatory Network Inference

Microarrays
BiochemistryBioengineeringBiomedical EngineeringBiotechnology
2015English

Preparation, Review, and Approval of Implementation Plans for Nuclear Safety Requirements

1994English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy